Inventor
ROBICHAUD ALBERT JEAN
US85 patents
⚠️ This page may combine multiple inventors who share the name “ROBICHAUD ALBERT JEAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SAGE THERAPEUTICS INC
43 patentsUS10246482B2Apr 2, 2019
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC38 citations98
US9725481B2Aug 8, 2017
19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
SAGE THERAPEUTICS INC46 citations98
US9512165B2Dec 6, 2016
19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
SAGE THERAPEUTICS INC71 citations98
US9365611B2Jun 14, 2016
19-NOR neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC49 citations98
US11241446B2Feb 8, 2022
19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
SAGE THERAPEUTICS INC12 citations94
US11149054B2Oct 19, 2021
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC14 citations94
US11111266B2Sep 7, 2021
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC15 citations94
US11104701B2Aug 31, 2021
Neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC16 citations94
US10723758B2Jul 28, 2020
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC20 citations94
US10696712B2Jun 30, 2020
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC21 citations94
US10342810B2Jul 9, 2019
19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
SAGE THERAPEUTICS INC17 citations94
US10259840B2Apr 16, 2019
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC30 citations94
US10201550B2Feb 12, 2019
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC23 citations94
US10172871B2Jan 8, 2019
19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
SAGE THERAPEUTICS INC20 citations94
US11926646B2Mar 12, 2024
C7 substituted oxysterols and methods of use thereof
SAGE THERAPEUTICS INC5 citations86
US11905309B2Feb 20, 2024
Neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC5 citations86
US11884697B2Jan 30, 2024
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC6 citations86
US11878995B2Jan 23, 2024
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC5 citations86
US11780875B2Oct 10, 2023
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC4 citations86
US11732000B2Aug 22, 2023
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC6 citations86
US11613556B2Mar 28, 2023
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC6 citations86
US11542297B2Jan 3, 2023
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC9 citations86
US11530237B2Dec 20, 2022
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC9 citations86
US11396525B2Jul 26, 2022
C17, C20, and C21 substituted neuroactive steroids and their methods of use
SAGE THERAPEUTICS INC8 citations86
US11344563B2May 31, 2022
19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
SAGE THERAPEUTICS INC8 citations86
US11261211B2Mar 1, 2022
19-NOR neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC8 citations86
US11149057B2Oct 19, 2021
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC9 citations86
US10870677B2Dec 22, 2020
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC13 citations86
US10774108B2Sep 15, 2020
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC12 citations86
US11498940B2Nov 15, 2022
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC8 citations85
US10822370B2Nov 3, 2020
19-nor neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC13 citations85
US11407782B2Aug 9, 2022
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC5 citations84
US11147877B2Oct 19, 2021
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC8 citations84
US11149056B2Oct 19, 2021
C7 substituted oxysterols and methods of use thereof
SAGE THERAPEUTICS INC5 citations84
US11046728B2Jun 29, 2021
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC8 citations84
US10765685B2Sep 8, 2020
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC4 citations84
US10759828B2Sep 1, 2020
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC15 citations84
US10745436B2Aug 18, 2020
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC9 citations84
US10377790B2Aug 13, 2019
19-nor neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC8 citations84
US10023606B2Jul 17, 2018
19-nor neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC11 citations84
US12473327B2Nov 18, 2025
Neuroactive steroids, compositions and uses thereof
SAGE THERAPEUTICS INC1 citations75
US12268697B2Apr 8, 2025
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC1 citations75
US12060386B2Aug 13, 2024
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC3 citations75
UNIV WASHINGTON
3 patentsUS9630986B2Apr 25, 2017
Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
UNIV WASHINGTON49 citations97
US9676812B2Jun 13, 2017
Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
UNIV WASHINGTON15 citations92
US10342809B2Jul 9, 2019
Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
UNIV WASHINGTON11 citations83
WYETH CORP
3 patentsUS7423158B2Sep 9, 2008
Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of β-secretase
WYETH CORP35 citations91
US7238696B2Jul 3, 2007
Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
WYETH CORP12 citations82
US7256198B2Aug 14, 2007
Pyrimidoindolones and methods for using same
WYETH CORP11 citations76
WYETH LLC
1 patentShowing the top 50 of 85 patents by PatentIndex Score.